Immune Sera and Monoclonal Antibodies Define Two Configurations for the Sialyl Tn Tumor Antigen

Cancer Research

Volumn 55, Issue 15, 1995, Pages 3364-3368

  Zhang, Shengle ^a   Walberg, Linda A ^a   Ogata, Shunichiro ^b   Itzkowitz, Steven H ^b   Koganty, R Rao ^c   Reddish, Mark ^c   Gandhi, Sham S ^c   Longenecker, B Michael ^c   Lloyd, Kenneth O ^a   Livingston, Philip O ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c Biomira Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; MONOCLONAL ANTIBODY; SIALOGLYCOPROTEIN; TUMOR ANTIGEN;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL SPECIFICITY; FEMALE; HUMAN; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINE PRODUCTION;

ANIMAL; ANTIBODY SPECIFICITY; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CELL LINE; FEMALE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MUCINS; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR MARKERS, BIOLOGICAL;

EID: 0029152203     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Itzkowitz, S. H., Bloom, E. J., Kokal, W. A., Modin, G., Hakomori, S., and Kim, Y. S. Sialosyl Tn: a novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer (Phila.), 66: 1960–1966, 1990.
2. Itzkowitz, S. H., Kjeldsen, T., Friera, A., Hakomori, S., Yang, U., and Kim, Y. S. Expression of Tn, sialosyl-Tn and T antigens in human pancreas. Gastroenterology, 100: 1691–1700, 1991.
3. Werther, J. L., Rivera-MacMurray, S., Bruckner, H. B., Tatematsu, M., and Itzkowitz, S. H. Mucin-associated sialosyl-Tn antigen expression in gastric cancer correlates with an adverse outcome. Br. J. Cancer, 69: 613–616, 1994.
4. Thor, A., Ohuchi, N., Szpak, C. A., Johnston, W. W., and Schlom, J. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res., 46: 3118–3124, 1986.
5. Xu, M., Real, F. X., Welt, S., Schussler, M. H., Oettgen, H. F., and Old, L. J. Expression of TAG-72 in normal colon, transitional mucosa, and colon cancer. Int. J. Cancer, 44: 985–989, 1989.
6. Gold, D. V., and Mattes, M. J. Monoclonal antibody B72.3 reacts with a core region structure of O-linked carbohydrates. Tumor Biol., 9: 137–144, 1988.
7. Kjeldsen, T., Clausen, H., Hirohashi, S., Ogawa, T., Iijima, H., and Hakomori, S. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2→6 ααN-acetylgalactosaminyl (Sialosyl-Tn) epitope. Cancer Res., 48: 2214–2220, 1988.
8. Guadagni, F., Roselli, M., Amato, T., Cosimelli, M., Mannella, E., Perri, P., Abbolito, M. R., Cavaliere, R., Colcher, D., Greiner, J. W., and Schlom, J. Tumor-associated glycoprotein-72 serum levels complement carcinoembryonic antigen levels in mono-toring patients with gastrointestinal carcinoma. A longitudinal study. Cancer (Phila.), 68: 2443–2450, 1991.
9. Schlom, J., Eggensperger, D., Colcher, D., Molinolo, A., Houchens, D., Miller, L. S., Hinkle, G., and Siler, K. Therapeutic advantage of high-affinity anticarcinoma radio-immunoconjugates. Cancer Res., 52: 1067–1072, 1992.
10. 177lutetium-labeled immunoconjugate. Cancer Res., 51: 2889–2896, 1991.
11. Meredith, R. F., Khazaeli M. B., Plott, W. E., Saleh, M. N., Liu, T., Allen, L. F., Russell, C. D., Orr, R. A., Colcher, D., Schlom, J., Shochat, D., Wheeler, R. H., and LoBuglio, A. F. Phase I trial of iodine-131-chimeric B72.3 (human IgG4) in metastatic colorectal cancer. J. Nucl. Med., 33: 23–29, 1992.
12. O’Boyle, K. P., Zamore, R., Adluri, S., Cohen, A., Kemeny, N., Welt, S., Lloyd, K. O., Oettgen, H. F., Old, L. J., and Livingston, P. O. Immunization of colorectal cancer patients with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn. Cancer Res., 52: 5663–5667, 1992.
13. Adluri, S., Helling F., Ogata, S., Zhang, S., Itzkowitz, S. H., Lloyd, K. O., and Livingston, P. O. Immunogenicity of synthetic TF- and sTn-KLH conjugates in colorectal carcinoma patients. Cancer Immunol. Immunother., in press, 1995.
14. MacLean, G. D., Reddish, M., Koganty, R. R., Wong, T., Gandhi, S., Smolenski, M. Samuel, J., Nabholtz, J. M., and Longenecker, B. M. Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant. Cancer Immunol. Immnother., 36: 215–222, 1993.
15. Longenecker, B. M., Reddish, M., Miles, D., and MacLean, G. D. Synthetic tumor-associated sialyl-Tn antigen as an immunotherapeutic cancer vaccine. Vaccine Res., 2: 151–162, 1993.
16. Nakada, H., Inoue, M., Numata, Y., Tanaka, N., Funakoshi, I., Fukui, S., Mellors, A., and Yamashina, I. Epitopic structure of Tn glycophorin A for an anti-Tn antibody (MLS 128). Proc. Natl. Acad. Sci. USA, 90: 2495–2499, 1993.
17. Carlesson, J., Drevin, H., and Axen, R. Protein thiolation and reversible protein-protein conjugation N-succinimidyl-3-(2-pyridyldithio)propionate, a new heterobi-functional reagent. Biochem. J., 173: 727–737, 1978.
18. Colcher, D., Horan Hand, P., Nuti, M., and Schlom, J. A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc. Natl. Acad. Sci. USA, 78: 3199–3203, 1981.
19. Muraro, R., Kuroki, M., Wunderlich, D., Poole, D. J., Colcher, D., Thor, A., Greiner. J. W., Simpson, J. F., Molinolo, A., Noguchi, P., and Schlom, J. Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen. Cancer Res., 48: 4588–4596, 1988.
20. Kensil, C. R., Patel, U., Lennick, M., and Marciani, D. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria molina cortex. J. Immunol., 146: 431–437, 1991.
21. Livingston, P. O., Ritter, G., and Calves, M. J. Antibody response after immunization with the gangliosides GM1, GM2, GM3, GD2, and GD3 in the mouse. Cancer Immunol. Immunother., 29: 179–184, 1989.
22. Ogata, S., Chen, A., and Itzkowitz, S. H. Use of model cell lines to study the biosynthesis and biological role of cancer-associated sialosyl-Tn antigen. Cancer Res., 54: 4036–4044, 1994.
23. Kurosaka, A., Kitagawa, H., Fukui, S, Numata, Y., Nakada, H., Funakoshi, I., Kawasaki, T., Ogawa, T., Iijima, H., and Yamashina, I. A monoclonal antibody that recognizes a cluster of a disaccharide, NeuAcα2→6GalNAc, in mucin-type glycoproteins. J. Biol. Chem., 263: 8724–8726, 1988.
24. Gum, J. R., Byrd, J. C., Hicks, J. W., Toribara, N. W., Lamport, D., and Kim, Y. S. Molecular cloning of human intestinal cDNAs. Sequence analysis and evidence for genetic polymorphism. J. Biol. Chem., 264: 6480–6487, 1989.
25. Gum, J. R., Hicks, J. W., Swallow, D. M., Lagace, R. L., Byrd, J. C., Lamport, D. A. T., Siddiki, B., and Kim, Y. S. Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. Biochem. Biophys. Res. Commun., 171: 407–415, 1990.
26. Nuti, M., Teramoto, Y. A., Mariani-Costantini, R., Horan Hand, P., Colcher, D., and Schlom, J. A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populations. Int. J. Cancer., 29: 539–545, 1982.
27. Johnson, V. G., Schlom J., Paterson, A. J., Bennett, J., Magnani, J. L., and Colcher, D. Analysis of human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. Cancer Res., 46: 850–857, 1986.
28. Gendler, S. J., Spicer, A. P., Lalani, E.-N., Duhig, T., Peat, N., Burchell, J., Pember-ton, L., Boshell, M., and Taylor-Papadimitriou, J. Structure and biology of a carcinoma-associated mucin, MUC1. Am. Rev. Respir. Dis., 144: S42-S47, 1991.
29. Ørntoft, T. F., Harving, N., and Langkilde, N. C. O-linked mucin-type glycoproteins in normal and malignant colon mucosa: lack of T-antigen expression and accumulation of Tn and sialosyl-Tn antigen in carcinomas. Int. J. Cancer, 45: 666–672, 1990.